Cefuracetime

CAS No. 39685-31-9

Cefuracetime( SKF81367 )

Catalog No. M24358 CAS No. 39685-31-9

Cefuracetime (SKF81367) is a cephalosporin antibiotic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 277 In Stock
10MG 397 In Stock
25MG 656 In Stock
50MG 888 In Stock
100MG 1251 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cefuracetime
  • Note
    Research use only, not for human use.
  • Brief Description
    Cefuracetime (SKF81367) is a cephalosporin antibiotic.
  • Description
    Cefuracetime (SKF81367) is a cephalosporin antibiotic.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SKF81367
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39685-31-9
  • Formula Weight
    423.4
  • Molecular Formula
    C17H17N3O8S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    O=C(C(N12)=C(COC(C)=O)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=N\OC)=O)C1=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shahid M, et al. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Crit Rev Microbiol. 2009;35(2):81-108.
molnova catalog
related products
  • 2’-Deoxy-N4-methylcy...

    2’-Deoxy-N4-methylcytidine (N(3)-Methyl-2'-deoxycytidine) is a purine nucleoside analog with potential antitumor activity for the study of apoptosis.

  • (S)-5-chloro-N-(1-((...

    (S)-5-chloro-N-(1-((4-chlorophenyl)amino)-1-oxo-3-phenylpropan-2-yl)-2-hydroxybenzamide has antifungal and tuberculostatic activities.

  • N6-Bz-5-O-DMTr-3-deo...

    N6-Bz-5'-O-DMTr-3'-deoxyadenosine-2'-O-CED-phosphoramidite, an adenine nucleoside analog, has potential vasodilator and anticancer activities relevant to cancer research.